Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022624
Filing Date
2022-02-14
Accepted
2022-02-14 16:00:26
Documents
1
Group Members
DALIA BLEYERIAN CHAROUBNEXTECH V GP S.A.R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm226050d9_sc13ga.htm SC 13G/A 122205
  Complete submission text file 0001104659-22-022624.txt   123781
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 22631031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G/A